Fibromyalgia
Fibromyalgia
Fibromyalgia is a chronic pain syndrome of unknown etiology. The disease is characterized by widespread musculoskeletal pain, fatigue, and multiple tender points in the neck, spine, shoulders, and hips. An estimated 3 to 6 million Americans are afflicted by fibromyalgia, which is often poorly controlled by standard pain medications.
Fibromyalgia patients frequently self-report using cannabis therapeutically to treat symptoms of the disease, and physicians – where legal to do so – often recommend the use of cannabis to treat musculoskeletal disorders. To date however, only one clinical trial is available in the scientific literature assessing the use of cannabinoids to treat the disease.
Writing in the July 2006 issue of the journal Current Medical Research and Opinion, investigators at Germany's University of Heidelberg evaluated the analgesic effects of oral THC in nine patients with fibromyalgia over a 3-month period. Subjects in the trial were administered daily doses of 2.5 to 15 mg of THC, but received no other pain medication during the trial. Among those participants who completed the trial, all reported a significant reduction in daily recorded pain and electronically induced pain.
Previous clinical and preclinical trials have shown that both naturally occurring and endogenous cannabinoids hold analgesic qualities, particularly in the treatment of cancer pain and neuropathic pain, both of which are poorly treated by conventional opioids. As a result, some experts have suggested that cannabinoid agonists would be applicable for the treatment of chronic pain conditions unresponsive to opioid analgesics such as fibromyalgia, and they theorize that the disease may be associated with an underlying clinical deficiency of the endocannabinoid system.
Related News Items
No documents found.
Recommended Doctors
No documents found.
CPN Interviews Suzanne Jones of Missouri
Suzanne's misdiagnosis almost claimed her life. The seemingly endless flow of pharmaceuticals only exacerbated her fragile condition. Her form of cancer, Systemic Mastocytosis, seemed hopeless to treat until she discovered cannabis.
CPN Interviews Kathleen Wolff of Missouri
In July of 1993, Kathleen's life changed forever when her car was struck from behind. Suffering a traumatic brain injury (TBI), Kathleen seemed trapped between her debilitating condition and the pharmaceuticals that sapped her humanity in exchange for temporary relief.
CPN Interviews Heath Poland of Missouri
Heath suffers from ADHD (Attention Deficit Disorder) and Bipolar Disorder. Like so many who suffer from mental illness, he spent much of his life mis-diagnosed and improperly and/or over-medicated.
CPN Interviews Greg Terry of Missouri
Ever since Greg was 17, he has battled Crohn's Disease, Though he has run the gamut of of surgeries and pharmaceutical meds to treat this debilitating disease, only one holistic treatment has given him lasting relief from his symptoms. So, for 34 years, Cannabis has been his medicine of choice.
CPN Interviews Cory Harlan of Missouri
Cory has suffered greatly in his 29 years. Because of a traumatic brain injury (TBI) as an infant, he developed a condition called Mesial Temporal Sclerosis. He has been in and out of hospitals and institutions ever since. Cannabis relieves his pain and seizures and has helped him return to college.
CPN Interviews Brian Chitwood of Missouri
I first met Brian at the 2009 Joplin Cannabis Revival. Brian is a Hodgkin's Lymphoma survivor. He attributes his recovery to his use of cannabis as an adjunct to the chemotherapy he received.
Signup for Updates
Stay informed about recent news, upcoming events, and more!